REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Whole Live Micro-organism, Cell, Or Virus Containing > Virus Or Bacteriophage Virus Or BacteriophageVirus Or Bacteriophage patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.08/16/07 - 20070190033 - Bacteriophage-containing therapeutic agents The present invention relates in its broadest aspect to combined phage/antibiotic therapy. More particularly, it relates to use of (i) one or more bacteriophages and (ii) one or more antibiotics in the manufacture of a combined product for simultaneous, separate or sequential administration of (i) and (ii) to treat a ... 07/19/07 - 20070166287 - Oncolytic virus The present invention is directed to a method of reducing the viability of a tumor cell involving administering a virus that is not a common human pathogen to the tumor cell. Preferably, the virus exhibits differential susceptibility, in that normal cells are not affected by the virus. This differential susceptibility ... 07/05/07 - 20070154459 - Method for bacteriophage delivery and amplification Disclosed are methods of selecting wide host range bacteriophage capable of growing in a plurality of bacteria including pathogenic and non-pathogenic bacteria and bacteriophage selected by the methods. Also disclosed are methods of treating a subject infected with a pathogenic bacterium using bacteriophage and methods of decontaminating objects using bacteriophage. ... 06/21/07 - 20070141033 - Purging of cells using viruses The subject invention relates to viruses that are able to purge (reduce or eliminate) undesirable cells in a mixture of cells. Undesirable cells can include neoplastic cells, cells mediating graft-versus host diseases, and autoimmune cells. The subject invention also relates to the purging of undesirable cells from bone marrow or ... 06/14/07 - 20070134207 - Isolated phages and their use in food or pet food products The present invention relates to phage isolates having a strong lytic activity against pathogenic Enterobacteriaceae such as Escherichia coli and/or Salmonella strains and their use in various human or pet food products for the treatment or prevention of bacterial diseases caused by pathogenic Enterobacteriaceae such as Escherichia coli , in ... 06/07/07 - 20070128170 - Compositions of ndv and methods of use thereof for treatment of cancer The present invention discloses methods for inducing regression of a tumor in a subject by administering a pharmaceutical composition comprising a lentogenic strain of Newcastle disease virus (NDV). A preferred viral strain of NDV for inducing regression of a tumor in a subject is a clonal strain of NDV, the ... 04/05/07 - 20070077235 - Composition and method of treating mastitis A composition and method for treating bacterial infections by the use of an effective amount of at least one lytic specific for the bacteria causing specific. The lytic enzyme is genetically coded for by a bacteriophage which may be specific for said bacteria. The enzyme may be at least one ... 01/25/07 - 20070020241 - Use of photosensitisation A composition comprising a conjugate of a photosensitiser and a bacteriophage is provided. The conjugate may be used to kill bacteria, particularly MRSA, EMRSA, VRSA, hetero-VRSA or CA-MRSA in a targeted method of photodynamic therapy. ... 01/25/07 - 20070020240 - Defined dose therapeutic phage The invention provides therapeutic, defined-dose anti-bacterial phage preparations, methods to make such preparations, methods to treat bacterial infections using such preparations and methods to diagnose bacterial infections using such preparations. ... 01/18/07 - 20070014770 - Bacteriophage and their uses There is provided a bacteriophage capable of lysing a P. acnes bacterium and incapable of lysing a bacterium which is not P. acnes, and which is incapable of sustaining lysogeny in a bacterium. There is also provided a pharmaceutical composition comprising such a bacteriophage. ... 12/21/06 - 20060286076 - Device and method for applying active substances to the surface of a wound The invention relates to the application of active substances to the surface of a wound. An insert made of porous material is applied to the surface of the wound, and a sealing overlay is used to cover the surface of the wound and the inlay. The liquid active substance is ... 10/05/06 - 20060222632 - Disinfection of foodstuffs A method of disinfection of livestock is provided. The method comprises administering at least one bacteriophage in an effective amount to said livestock to reduce the number of Campylobacter spp present in the gastro-intestinal tract of said livestock. The bacteriophage are selected from CP8 (NCIMB Accession No. 41184) and CP34 ... 07/13/06 - 20060153811 - Use of viruses and virus-resistant microorganisms for controlling microorganism populations A lytic virus specific for a target strain of a microorganism and substantially free of undesirable genes may be utilized in processes including control of populations of microorganisms. The virus may include a host-range mutant, or “h-mutant.” A method for generating virus includes growing virus-resistant variants of a target strain ... 06/29/06 - 20060140911 - Bacteriophage for the treatment of bacterial biofilms The present invention provides a composition for treating a bacterial biofilm, comprising a first bacteriophage that is capable of infecting a bacterium within said biofilm, and a first polysaccharide lyase enzyme that is capable of degrading a polysaccharide within said biofilm. The composition preferably further comprises a pharmaceutically-acceptable antimicrobial agent, ... 06/15/06 - 20060127364 - Insect viruses and their uses in protecting plants The present invention relates to an isolated small RNAvirus capable of infecting insect specifies including Heliothis species, and to the nucleotide sequences and proteins encoded thereby. The invention contemplates uses of the virus in controlling insect attach in plants. ... 05/11/06 - 20060099189 - Anti-cancer virus desensitization method A mammalian subject having a tumor is treated by a method comprising administering to the subject an amount of a Newcastle disease virus effective to treat the subject, wherein the virus is administered to the subject in one or more cycles; at least one cycle comprises administering sequentially one or ... 02/23/06 - 20060039894 - Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response The present invention relates to an avirulent, oncolytic herpes simplex virus modified from a wild-type herpes simplex virus so that both γ134.5 genes of the virus have been deleted and each replaced with an interferon-resistance gene that is expressed as an immediate-early gene. The present invention also relates to a ... 01/26/06 - 20060018884 - Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent A method for treating human tumor cells to induce apoptotic cell death thereof includes the step of infecting the tumor cells with a combination of the Herefordshire strain of Newcastle Disease Virus and a chemotherapeutic agent. The range of concentrations of chemotherapeutic agent/Herefordshire strain is in the range of 100/1 ... 11/24/05 - 20050260171 - Compositions containing bacteriophages and method of using bacteriophages to treat infections Purified, host-specific, non-toxic, wide host range and virulent bacteriophage preparations that are effective in killing bacterial organisms in vivo are disclosed. Also disclosed are compositions containing these bacteriophages, methods of making the bacteriophage preparations and methods of treating bacterial infections using the compositions. Methods of treating bacterial infections using the ... 11/03/05 - 20050244383 - Method and device for sanitation using bacteriophages Methods and devices for sanitation using bacteriophage are disclosed. According to one embodiment of the present invention, a method for sanitation using at least one bacteriophage includes the steps of (1) storing the at least one bacteriophage in a container; and (2) applying the at least one bacteriophage to a ... 10/13/05 - 20050226851 - Lysin-deficient bacteriophages having reduced immunogenicity The present invention features therapeutic bacteriophage deficient in the lysin protein (“Lys minus” phage). Lys minus bacteriophage are incapable of facilitating efficient lysis of the bacterial host since the enzymatic activity of the lysin of the phage is needed for breaking down the peptidoglycan layer of the bacterial cell wall. ... 10/06/05 - 20050220770 - Immobilisation and stabilisation of virus The present invention relates to a method for immobilisation and optional stabilisation of viruses whilst retaining the viral biological activity and the use of immobilised virus in therapy. In particular, the immobilised virus relates to immobilised bacteriophage and their use as an antibiotic or bacteriostatic agent and in the treatment ... 09/22/05 - 20050208024 - Oncolytic virus therapy A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic ... 08/11/05 - 20050175594 - Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants The present invention relates to virulent (lytic) Listeria monocytogenes phage from the Myoviridae family, preferably P100, alone or in combination with other virulent phages. P100 and the endolysin from P100 can be administered to food products, to the components that will be added to food products, and/or to the infrastructure ... 06/23/05 - 20050136037 - Bacteriophage for lysis of methylobacterium and compositions and uses thereof The invention relates to a novel bacteriophage which is lytic for species of the genus Methylobacterium, Human Blood Bacterium (HBB) or both, and derivatives, progeny and recombinant and mutated forms thereof. The invention further relates to compositions, methods and kits for using the bacteriophage of the invention in agricultural and ... ### FreshPatents.com Support |